University Medical Imaging Toronto, Joint Department of Medical Imaging - University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, Canada
Auto-generated profile, based on publicly available information
Hyun-Jung Jang
University Medical Imaging Toronto, Joint Department of Medical Imaging - University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, Canada
Contrast-enhanced US improves patient care, as a supplement to CT or MRI, in the evaluation of liver and kidney masses that are indeterminate at CT or MRI and extends noninvasive assessment to pati... Contrast-enhanced US (CEUS) has an important role as a supplement to CT or MRI in clinical practice. The main established utilizations are in the liver and the kidney. The primary advantages of CEU...
Contrast-enhanced ultrasound (CEUS) is a powerful technique for differentiating focal liver lesions (FLLs) without the risks of potential nephrotoxicity or ionizing radiation. In the diagnostic algorithm for FLLs on CEUS, washout is an important feature, as its presence is highly suggestive of malignancy and its characteristics are useful in distinguishing hepatocellular from nonhepatocellular malignancies. Interpreting washout on CEUS requires an understanding that microbubble contrast agents are strictly intravascular, unlike computed tomography or magnetic resonance imaging contrast agents. This review explains the definition and types of washout on CEUS in accordance with the 2017 version of the CEUS Liver Imaging Reporting and Data System and presents their applications to differential diagnosis with illustrative examples. Additionally, we propose potential mechanisms of rapid washout and describe the washout phenomenon in benign entities.
CEUS LI-RADS provided high specificity for noninvasive imaging-based diagnosis of hepatocellular carcinoma, removing the need for tissue diagnosis; in addition, it allowed for accurate categorizati... Purpose To validate the contrast agent–enhanced US Liver Imaging Reporting and Data System (CEUS LI-RADS) algorithm for accurate diagnosis of hepatocellular carcinoma (HCC) and categorization of al...
Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024 evaluates both intralesional and perilesional tumor viability to assign a single treatment response category: nonviable, equivocal, or viable.
1 August 2013 in American Journal of Roentgenology
OBJECTIVE. The purpose of this study was to identify the essential number of phases from multiphasic CT for 1- to 2-cm hepatocellular carcinoma (HCC) on surveillance ultrasound and to compare the results with the American Association for the Study of Liver Disease (AASLD) standard (arterial phase hypervascularity and portal venous phase [PVP] or delayed phase hypovascularity). MATERIALS AND METHODS. The study included 110 newly detected nodules (1–2 cm; 36 HCC, 74 benign) in 96 patients detected in an HCC surveillance program. Three radiologists prospectively evaluated the attenuation of each nodule relative to the liver on each phase of quadriphasic CT. Univariate and multivariate logistic regression analyses were used to identify parameters associated with HCC. Multiple combinations of phases were compared with the AASLD standard. RESULTS. Only arterial phase hypervascularity and delayed phase hypovascularity were significantly associated with HCC both on univariate (odds ratio, arterial phase 7.51 [95%...